Synovial Fluid Bank From Arthritic Patients
NCT00512343 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-05-15
Summary
The objectives of this group project is to collect synovial fluid (SF) and paired sera and carry out preclinical studies to evaluate, alone or by combination testings, the potential of novel biomarkers for their prevalence and diagnostic/prognostic values in patients with arthritis, and to determine how therapeutic intervention regulate their levels.
Conditions
Sponsors & Collaborators
-
Canadian Arthritis Network
collaborator NETWORK -
Gilles Boire
lead OTHER
Principal Investigators
-
Gilles Boire, MD, MSc · CHUS and Université de Sherbrooke
Eligibility
- Min Age
- 3 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2027-12-31
- Completion
- 2030-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients
NCT05341908 ·Status: COMPLETED
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001679 ·Status: COMPLETED
-
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 ·Status: RECRUITING
-
Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years
NCT02894047 ·Status: COMPLETED
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
NCT00781469 ·Status: TERMINATED
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
Identification of New Prognostic Markers in Psoriatic Arthritis
NCT03455166 ·Status: COMPLETED ·Phase: NA
-
Rheumatoid Arthritis Synovial Tissue Biopsy Study
NCT07000890 ·Status: COMPLETED ·Phase: NA
-
Corticosteroid Therapy for Persistent Synovitis in Acute Septic Arthritis on Native Joint
NCT05531227 ·Status: UNKNOWN
-
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
NCT01211678 ·Status: COMPLETED
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
NCT00522184 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
NCT00242853 ·Status: COMPLETED
-
Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis
NCT04953871 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
NCT05808309 ·Status: WITHDRAWN
-
Biomarkers in Chronic Arthritis
NCT02909998 ·Status: COMPLETED
-
An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis
NCT07052032 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
NCT02525042 ·Status: COMPLETED
-
Indications and Interest of US-guided Synovial Biopsies Performed in Clinical Practice
NCT03417167 ·Status: COMPLETED
-
Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes
NCT00845949 ·Status: WITHDRAWN
-
Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis
NCT05119452 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis
NCT03511625 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers
NCT02464384 ·Status: UNKNOWN ·Phase: NA
-
Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
NCT02742337 ·Status: UNKNOWN